Qiagen NV | QIA - Ordinary Share Capital

Stock Price
41.12
Daily Change
0.72 1.78%
Monthly
-11.44%
Yearly
9.14%
Q1 Forecast
40.37

Qiagen NV reported $216.56M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Akebia Therapeutics USD 2K 0 Mar/2025
Alaunos Therapeutics USD 2.21M 2.2M Sep/2025
Dianthus Therapeutics USD 42.85M 42.82M Sep/2025
Ionis Pharmaceuticals USD 161.14M 160.98M Sep/2025
IQVIA Holdings USD 169.6M 700K Dec/2025
Moderna USD 391M 2M Sep/2025
Organon & Co USD 259.98M 18K Sep/2025
Qiagen NV USD 216.56M 284.67K Dec/2025
Revvity USD 113.38M 2.7M Dec/2025
Tectonic Therapeutic USD 14.86M 111.83K Dec/2024
Viatris USD 1.16B 6.55M Sep/2025
Xeris Pharmaceuticals USD 165.53M 165.51M Sep/2025